Developed by Prof. Dr. Halit CANATAN, Assoc. Prof. Dr. Ahmet EKEN, Assoc. Prof. Dr. Mehmet Fatih YETKİN, Res. Asst. Dr. Kübra ASLAN, Lecturer Dr. Ayça KARA from the ERU Faculty of Medicine and Ameneh SABERİ, a graduate student at the Department of Medical Biology/ERU Graduate School of Health

Sciences, the national patent titled "Use of Empagliflozin in the Treatment of Multiple Sclerosis" has been registered by the Turkish Patent and Trademark Office.

We congratulate our researchers and wish them continued success.